Full Mouth Ultrasonic Debridement Carried Out Either by Piezoelectric or Magnetostrictive Device

NCT05279950 — Not applicable, Unknown, 52 participants, University of Siena

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

Clinical and Patient Centred Outcome Performance of Full Mouth Ultrasonic Debridement Carried Out for the Treatment of Periodontitis Performed Either by Piezoelectric or Magnetostrictive Device. A Randomized Controlled Clinical Trial

RegistryNCT05279950
StatusUnknown
PhaseNot applicable
Study typeInterventional; randomized, parallel, masking: double, treatment
Enrollment52 (Estimated)
SponsorUniversity of Siena (Other)
ConditionsPeriodontitis, Adult
InterventionsFull-mouth ultrasonic debridement with piezoelectric device (EMS, mini piezon), Full-mouth ultrasonic debridement with magnetostrictive device (Cavitron Select, Dentsply) (Device)
Datesstart 2022-04-10 (estimated), primary completion 2022-07-10 (estimated), completion 2022-10-30 (estimated), first posted 2022-03-15, last updated 2022-03-15
Locations1 site in Italy

Related Papers Related Patents Related Grants Related Experts
All trials for Periodontitis, Adult All trials of Full-mouth ultrasonic debridement with piezoelectric device (EMS, mini piezon) All trials of Full-mouth ultrasonic debridement with magnetostrictive device (Cavitron Select, Dentsply)

-Summary

Treatment of periodontitis requires removal of dental biofilm both through professional mechanical plaque removal and domiciliar oral hygiene procedures. This study aims to compare biometric and psychological results after professional treatment of periodontitis carried out by piezoelectric or magnetostrictive ultrasonic devices.

Expand all sections  ·  Collapse all

+Detailed description

Patients diagnosed with periodontitis will be assessed for eligibility criteria. Full-mouth periodontal assessment will be performed by an examiner to detect severity and extension of the disease. Thereafter, patient will receive oral hygiene instruction and a closed envelope with patient allocation will be opened. After the allocation to the intervention group, full-mouth ultrasonic debridement will be delivered to the patient by an operator and information about patient perception will be collected. Three months later, patients will be recalled for a new periodontal assessment.

+Arms and interventions

ArmTypeInterventionsDescription
PiezoelectricActive comparatorDevice: Full-mouth ultrasonic debridement with piezoelectric device (EMS, mini piezon)Full-mouth ultrasonic debridement will be performed with a ultrasonic tip (vibration frequence >18 kHz) powered by a piezoelectric device
MagnetostrictiveExperimentalDevice: Full-mouth ultrasonic debridement with magnetostrictive device (Cavitron Select, Dentsply)Full-mouth ultrasonic debridement will be performed with a ultrasonic tip (vibration frequence >18 kHz) powered by a magnetostrictive device.
  • Full-mouth ultrasonic debridement with piezoelectric device (EMS, mini piezon) (Device): the use of ultrasonic oscillating tips allows supragingival and subgingival biofilm and dental calculus removal
  • Full-mouth ultrasonic debridement with magnetostrictive device (Cavitron Select, Dentsply) (Device): the use of ultrasonic oscillating tips allows supragingival and subgingival biofilm and dental calculus removal

+Outcome measures

Primary outcomes

  • Pain perception [through study completition, 1 year]: vas scale (0-10) for perception of pain after treatment
  • noise [through study completition, 1 year]: vas scale (0-10) for perception of noise after treatment
  • vibration [through study completition, 1 year]: vas scale (0-10) for perception of vibration after treatment

Secondary outcomes

  • pocket closure [through study completition, 1 year]: change of pocket probing depth (millimeter) after treatment measured with a periodontal probe

+Eligibility

Sex: All, accepts healthy volunteers

Inclusion Criteria:

* >18 years
* periodontitis of stage 1 and 2
* absence of systemic chronic disease

Exclusion Criteria:

* anticoagulants treatment
* antibiotic treatment 3 months before the screening visit

+Locations (1)

FacilityCityCountryStatus
AOUSSienaItaly